Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 417 | 3 | RENAL CELL CARCINOMA//ANGIOMYOLIPOMA//PARTIAL NEPHRECTOMY | 30583 |
| 523 | 2 | RENAL CELL CARCINOMA//PARTIAL NEPHRECTOMY//KIDNEY NEOPLASMS | 15437 |
| 27542 | 1 | TEROXIRONE//CHEMOENDOCRINE TREATMENT//DOSE ASSESMENT | 246 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TEROXIRONE | authKW | 256234 | 1% | 100% | 2 |
| 2 | CHEMOENDOCRINE TREATMENT | authKW | 170821 | 1% | 67% | 2 |
| 3 | DOSE ASSESMENT | address | 128117 | 0% | 100% | 1 |
| 4 | ESTROGEN RECEPTOR LIPOMA | authKW | 128117 | 0% | 100% | 1 |
| 5 | FARESTON | authKW | 128117 | 0% | 100% | 1 |
| 6 | HETEROCYCLIC TRIOXIRANES | authKW | 128117 | 0% | 100% | 1 |
| 7 | HIGH DOSE TOREMIFENE | authKW | 128117 | 0% | 100% | 1 |
| 8 | RADIAT EMERGENCY MEDBUNKYO KU | address | 128117 | 0% | 100% | 1 |
| 9 | RENAL INTRATUBULAR NEOPLASIA | authKW | 128117 | 0% | 100% | 1 |
| 10 | SEX HORMONE UROL | address | 128117 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 3855 | 64% | 0% | 158 |
| 2 | Urology & Nephrology | 546 | 14% | 0% | 35 |
| 3 | Pharmacology & Pharmacy | 58 | 11% | 0% | 28 |
| 4 | Medicine, General & Internal | 14 | 5% | 0% | 13 |
| 5 | Pathology | 10 | 2% | 0% | 6 |
| 6 | Surgery | 9 | 6% | 0% | 14 |
| 7 | Endocrinology & Metabolism | 1 | 2% | 0% | 5 |
| 8 | Chemistry, Medicinal | 0 | 1% | 0% | 3 |
| 9 | Geriatrics & Gerontology | 0 | 0% | 0% | 1 |
| 10 | Engineering, Manufacturing | 0 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | DOSE ASSESMENT | 128117 | 0% | 100% | 1 |
| 2 | RADIAT EMERGENCY MEDBUNKYO KU | 128117 | 0% | 100% | 1 |
| 3 | SEX HORMONE UROL | 128117 | 0% | 100% | 1 |
| 4 | DANA FARBER HARVARD CANC CANC PROTEOM CORE | 64058 | 0% | 50% | 1 |
| 5 | PATHOLWILMOT CANC | 42704 | 0% | 33% | 1 |
| 6 | UROLWILMOT CANC | 42704 | 0% | 33% | 1 |
| 7 | ARTHUR JAMES CANC | 25622 | 0% | 20% | 1 |
| 8 | BIOL DOSE SECT | 25622 | 0% | 20% | 1 |
| 9 | GEORGE H WHIPPLE CANC | 4269 | 0% | 3% | 1 |
| 10 | SEX HORMONE | 3140 | 1% | 1% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER TREATMENT REPORTS | 88499 | 16% | 2% | 39 |
| 2 | CANCER CLINICAL TRIALS | 16007 | 2% | 3% | 4 |
| 3 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 15303 | 6% | 1% | 15 |
| 4 | PROGRESS IN SURGERY | 12198 | 1% | 5% | 2 |
| 5 | ONKOLOGIE | 5975 | 4% | 0% | 11 |
| 6 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 3783 | 4% | 0% | 11 |
| 7 | JOURNAL OF CLINICAL SURGERY-APPLIED PHYSIOLOGY & METABOLISM | 3766 | 0% | 3% | 1 |
| 8 | JAPANESE JOURNAL OF UROLOGY | 3283 | 0% | 3% | 1 |
| 9 | INVESTIGATIONAL NEW DRUGS | 3151 | 3% | 0% | 8 |
| 10 | CANCER TREATMENT REVIEWS | 1584 | 2% | 0% | 5 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |